Lassa Fever: Clinical Trials

1 trial for Lassa Fever, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow Lassa Fever: new trials by email Literature Review of Lassa Fever trials Research Report on Lassa Fever

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Trial to Evaluate the Safety, Immunogenicity and the Optimal Dose of MOPEVAC-Las Vaccine Candidate Against Lassa Fever
Low dose MOPEVAC-Las vaccine, Intermediate dose MOPEVAC-Las vaccine, High dose MOPEVAC-Las vaccine - Lassa Fever
Phase 1RecruitingInstitut Pasteur722026-09-282026-10-13

Broader conditions

Arenaviridae Infections (1)  ·  Hemorrhagic Fevers, Viral (1)  ·  Infections (1)  ·  RNA Virus Infections (1)  ·  Virus Diseases (1)

Interventions

Injections (1)  ·  Saline Solution (1)

Sponsors

Institut Pasteur (1)

Countries

France (1)

Top investigators

Sylvain Baize (1)